batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASH 2024 preview – Incyte gets a Monjuvi coup 25 November 2024 Halozyme abandons Evotec proposal 25 November 2024 Perspective's lead balloon 21 November 2024 Amgen pushes on in Steap1 19 November 2024 Jefferies 2024 – Nuvation lays out its US taletrectinib strategy 19 November 2024 Jefferies 2024 – Arvinas gets a degrader delay 19 November 2024 Merck finally gets under the skin with Keytruda 19 November 2024 Avenzo's second trip to China 18 November 2024 Load More